{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T05:20:28Z","timestamp":1700716828311},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1985,9]]},"DOI":"10.1007\/bf01252030","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T15:02:21Z","timestamp":1111590141000},"page":"255-269","source":"Crossref","is-referenced-by-count":17,"title":["Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: Central and peripheral influences"],"prefix":"10.1007","volume":"63","author":[{"given":"Liliane","family":"Peyrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Pequignot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Chauplannaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Aimard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpsyc.1975.01760190019001","volume":"32","author":"H. Beckmann","year":"1975","unstructured":"Beckmann, H., Goodwin, F. K.: Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Arch. Gen. Psych.32, 17?21 (1975).","journal-title":"Arch. Gen. Psych."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000117740","volume":"6","author":"H. Beckmann","year":"1980","unstructured":"Beckmann, H., Goodwin, F. K.: Urinary MHPG in subgroups of depressed patients and normal controls. Neuropsychobiology6, 91?100 (1980).","journal-title":"Neuropsychobiology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0033291700056658","volume":"5","author":"P. A. Bond","year":"1975","unstructured":"Bond, P. A., Dimitrakoudi, M., Howlett, D. R., Jenner, F. A.: Urinary excretion of the sulphate and glucuronide of 3-methoxy-4-hydroxyphenylethylene glycol in a manic depressive patient. Psychol. Med.5, 279?285 (1975).","journal-title":"Psychol. Med."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0006-2944(74)90025-8","volume":"10","author":"P. A. Bond","year":"1974","unstructured":"Bond, P. A., Howlett, D. R.: Measurement of the two conjugates of 3-methoxy-4-hydroxyphenylglycol in urine. Biochem. Med.10, 219?228 (1974).","journal-title":"Biochem. Med."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S0033291700045657","volume":"12","author":"P. A. Bond","year":"1972","unstructured":"Bond, P. A., Jenner, F. A., Sampson, G.: Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic depressive patients. Psychol. Med.12, 81?85 (1972).","journal-title":"Psychol. Med."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(84)90490-4","volume":"103","author":"C. Boudet","year":"1984","unstructured":"Boudet, C., Peyrin, L., Tavitian, E., Claustre, J., Favre, R.: Studies on the central or peripheral origin of free and sulfated 3,4-dihydroxyphenylacetic acid in rat plasma. Europ. J. of Pharmacol.103, 295?301 (1984).","journal-title":"Europ. J. of Pharmacol."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000117853","volume":"7","author":"M. S. Buchsbaum","year":"1981","unstructured":"Buchsbaum, M. S., Muscettola, G., Goodwin, F. K.: Urinary MHPG, stress response, personality factors and somatosensory evoked potentials in normal subjects and patients with major affective disorders. Neuropsychobiology7, 212?224 (1981).","journal-title":"Neuropsychobiology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archpsyc.1972.01750270022003","volume":"27","author":"W. E. Bunney","year":"1972","unstructured":"Bunney, W. E., Goodwin, F. K., Murphy, D. L.: The switch process in manicdepressive illness. Arch. Gen. Psychiatr.27, 312?317 (1972).","journal-title":"Arch. Gen. Psychiatr."},{"key":"CR9","first-page":"213","volume-title":"Frontiers in Biochemical and Pharmacological Research in Depression","author":"A. Carlsson","year":"1984","unstructured":"Carlsson, A.: Current theories on the mode of action of antidepressant drugs. In: Frontiers in Biochemical and Pharmacological Research in Depression (Usdin, E., \u00c5sberg, M., Bertilsson, L., Sj\u00f6qvist, F., eds.), pp. 213?221. New York: Raven Press. 1984."},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"Crawley, J. N., Maas, J. W., Roth, R. H.: Role of the nucleus locus coeruleus in sympathetic and central noradrenergic activation as reflected by changes in the norepinephrine metabolite 3-methoxy-4-hydroxyphenethylene glycol (MHPG) in rats. In: Catecholamines: Basic and Clinical Frontiers (Usdin, E., Kopin, I. J., Barchas, J., eds.), Vol. 1, pp. 678?680. Pergamon Press. 1979.","DOI":"10.1016\/B978-1-4832-8363-0.50206-8"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1176\/ajp.132.11.1141","volume":"132","author":"F. Deleon-Jones","year":"1975","unstructured":"Deleon-Jones, F., Maas, J. W., Dekirmenjian, H., Sanchez, J.: Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolites. Amer. J. Psych.132, 1141?1148 (1975).","journal-title":"Amer. J. Psych."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(72)92064-8","volume":"2","author":"M. H. Ebert","year":"1972","unstructured":"Ebert, M. H., Post, R. M., Goodwin, F. K.: Effect of physical activity on urinary MHPG excretion in depressed patients. Lancet2, 766 (1972).","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","volume":"26","author":"J. P. Feighner","year":"1972","unstructured":"Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., Munoz, R.: Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiat.26, 57?63 (1972).","journal-title":"Arch. Gen. Psychiat."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0024-3205(79)90208-X","volume":"24","author":"D. L. Garver","year":"1979","unstructured":"Garver, D. L., Davis, J. M.: Biogenic amine hypothesis of affective disorders. Life Sci.24, 383?394 (1979).","journal-title":"Life Sci."},{"key":"CR15","first-page":"1197","volume-title":"Psychopharmacology: A Generation of Progress","author":"E. S. Gershon","year":"1978","unstructured":"Gershon, E. S.: The search for genetic markers in affective disorders. In: Psychopharmacology: A Generation of Progress (Lipton, M. A., Dimascio, A., Killam, K. F., eds.), pp. 1197?1212. New York: Raven Press. 1978."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archpsyc.1973.04200030079012","volume":"29","author":"D. J. Goode","year":"1973","unstructured":"Goode, D. J., Dekirmenjian, H., Meltzer, H. Y., Maas, J. W.: Relation of exercise to MHPG excretion in normal subjects. Arch. Gen. Psychiat.29, 391?396 (1973).","journal-title":"Arch. Gen. Psychiat."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/B978-1-4832-8363-0.50572-3","volume-title":"Catecholamines Basic and Clinical Frontiers","author":"F. K. Goodwin","year":"1979","unstructured":"Goodwin, F. K., Potter, W. Z.: Norepinephrine metabolite studies in affective illness. In: Catecholamines Basic and Clinical Frontiers (Usdin, E., Kopin, I. J., Barchas J., eds.), Vol. 2, pp. 1863?1884. New York: Pergamon Press. 1979."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0006-8993(73)90548-9","volume":"61","author":"E. Hartmann","year":"1973","unstructured":"Hartmann, E., Schildkraut, J. J.: Desynchronized sleep and MHPG excretion: an inverse correlation. Brain Res.61, 412?416 (1973).","journal-title":"Brain Res."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archpsyc.1978.01770360014001","volume":"35","author":"L. E. Hollister","year":"1978","unstructured":"Hollister, L. E., Davis, K. L., Overall, J. E., Anderson, T.: Excretion of MHPG in normal subjects. Arch. Gen. Psychiat.35, 1410?1415 (1978).","journal-title":"Arch. Gen. Psychiat."},{"key":"CR20","doi-asserted-by":"crossref","unstructured":"Izzo, J. L., Horwitz, D., Reiser, H. R.: Reduction in human urinary MHPG excretion by guanethidine: urinary MHPG as index of sympathetic nervous activity. Life Sci.24, 1403?1406.","DOI":"10.1016\/0024-3205(79)90011-0"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00426320","volume":"51","author":"M. H. Joseph","year":"1976","unstructured":"Joseph, M. H., Baker, H. F., Johnstone, E. C., Crow, T. J.: Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients. Psychopharmacol.51, 47?51 (1976).","journal-title":"Psychopharmacol."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0006-8993(77)90626-6","volume":"125","author":"F. Karoum","year":"1977","unstructured":"Karoum, F., Moyer-Schwing, J., Potkin, S. G., Wyatt, R. J.: Presence of freesulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma. Brain Res.125, 333?339 (1977).","journal-title":"Brain Res."},{"key":"CR23","first-page":"1289","volume-title":"Psychopharmacology: A Generation of Progress","author":"K. A. Kessler","year":"1978","unstructured":"Kessler, K. A.: Tricyclic antidepressants: mode of action and clinical use. Psychopharmacology: A Generation of Progress (Lipton, M. A., Di Mascio, A., Killam, K. F., eds.), pp. 1289?1302. New York: Raven Press. 1978."},{"key":"CR24","first-page":"1845","volume-title":"Psychopharmacology: A Generation of Progress","author":"I. J. Kopin","year":"1978","unstructured":"Kopin, I. J.: Measuring turnover of neurotransmitters in human brain. In: Psychopharmacology: A Generation of Progress (Lipton, M. A., Di Mascio, A., Killam, K. F., eds.), pp. 1845?1847. New York: Raven Press. 1978."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-1017399","volume":"17","author":"J. Kopin","year":"1984","unstructured":"Kopin, J., Jimerson, D. C., Markey, S. P., Ebert, M. H., Polinsky, R. J.: Disposition and metabolism of MHPG in humans: application to studies in depression. Pharmacopsychiat.17, 3?8 (1984).","journal-title":"Pharmacopsychiat."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-1781(80)90030-X","volume":"3","author":"D. J. Kupfer","year":"1980","unstructured":"Kupfer, D. J., Holzer, B. C., Edwards, D. J., Coble, P. A., Spiker, D. G., Neil, J. F.: MHPG excretion and EEG sleep in primary depression. Psychiat. Res.3, 133?130 (1980).","journal-title":"Psychiat. Res."},{"key":"CR27","first-page":"1375","volume-title":"Psychopharmacology: A Generation of Progress","author":"M. Lader","year":"1978","unstructured":"Lader, M.: Current psychophysiological theories of anxiety. In: Psychopharmacology: A Generation of Progress (Lipton, M. A., Di Mascio, A., Killam, K. F., eds.), pp. 1375?1380. New York: Raven Press. 1978."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(81)90205-3","volume":"70","author":"J. F. Leckman","year":"1981","unstructured":"Leckman, J. F., Maas, J. W., Heninger, G. R.: Covariance of plasma free 3-methoxy-4-hydroxyphenylethylene glycol and diastolic blood pressure. Europ. J. of Pharmacol.70, 111?120 (1981).","journal-title":"Europ. J. of Pharmacol."},{"key":"CR29","first-page":"45","volume-title":"Frontiers in Biochemical and Pharmacological Research in Depression","author":"J. W. Maas","year":"1984","unstructured":"Maas, J. W.: Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites. In: Frontiers in Biochemical and Pharmacological Research in Depression (Usdin, E., \u00c5sberg, M., Bertilsson, L., Sj\u00f6qvist, F., eds.), pp. 45?55. New York: Raven Press. 1984."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/230330a0","volume":"270","author":"J. W. Maas","year":"1971","unstructured":"Maas, J. W., Dekirmanjian, H., Fawcett, J. A.: Catecholamine metabolism and stress, Nature270, 330?331 (1971).","journal-title":"Nature"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000468112","volume":"9","author":"J. W. Maas","year":"1974","unstructured":"Maas, J. W., Dekirmenjian, H., Fawcett, J. A.: MHPG excretion by patients with affective disorders. Int. Pharmacopsych.9, 14?26 (1974).","journal-title":"Int. Pharmacopsych."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/B978-0-08-017922-3.50209-4","volume-title":"Frontiers in Catecholamine Research","author":"J. W. Maas","year":"1973","unstructured":"Maas, J. W., Dekirmenjian, H., Jones, F.: The identification of depressed patients who have a disorder of NE metabolism and\/or disposition. In: Frontiers in Catecholamine Research (Usdin, E., Snyder, S., eds.), pp. 1091?1096. New York: Pergamon Press. 1973."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archpsyc.1968.01740080001001","volume":"19","author":"J. W. Maas","year":"1968","unstructured":"Maas, J. W., Fawcett, J. A., Dekirmenjian, H.: 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depressive states. A pilot study. Arch. Gen. Psych.19, 129?134 (1968).","journal-title":"Arch. Gen. Psych."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.472724","volume":"205","author":"J. W. Maas","year":"1979","unstructured":"Maas, J. W., Hattox, S. E., Greene, N. M., Landis, D. H.: 3-methoxy-4-hydroxyphenylethyleneglycol production by humain brainin vivo. Science205, 1025?1027 (1979).","journal-title":"Science"},{"key":"CR35","first-page":"147","volume":"163","author":"J. W. Maas","year":"1968","unstructured":"Maas, J. W., Landis, D. H.:In vivo studies of the metabolism of norepinephrine in central nervous system. J. Pharmacol. Exp. Therap.163, 147?162 (1968).","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-08-017922-3.50030-7","volume-title":"Frontiers in Catecholamines Research","author":"J. L. Meek","year":"1973","unstructured":"Meek, J. L., Foldes, A.: Sulfate conjugates in the brain. In: Frontiers in Catecholamines Research (Usdin, E., Snyder, S., eds.), pp. 167?171. New York: Pergamon Press. 1973."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000117681","volume":"5","author":"I. Modai","year":"1979","unstructured":"Modai, I., Apter, A., Golomb, M., Wijsenbeek, H.: Response to amitriptyline and urinary MHPG in bipolar depressive patients. Neuropsychobiol.5, 181?184 (1979).","journal-title":"Neuropsychobiol."},{"key":"CR38","first-page":"535","volume":"13","author":"M. Paget","year":"1955","unstructured":"Paget, M., Gontier, M., Liefooghe, J.: Recherches sur le dosage de la cr\u00e9atinine urinaire. Ann. Biol. Clin.13, 535?553 (1955).","journal-title":"Ann. Biol. Clin."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00433009","volume":"79","author":"L. Peyrin","year":"1983","unstructured":"Peyrin, L., Pequignot, J. M.: Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide. Psychopharmacology79, 16?20 (1983).","journal-title":"Psychopharmacology"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archpsyc.1978.01770350104010","volume":"35","author":"D. Pickar","year":"1978","unstructured":"Pickar, D., Sweeney, D. R., Maas, J. W., Heninger, G. R.: Primary affective disorders, clinical state change and MHPG excretion. Arch. Gen. Psych.35, 1378?1383 (1978).","journal-title":"Arch. Gen. Psych."},{"key":"CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01245333","volume":"35","author":"P. Riederer","year":"1974","unstructured":"Riederer, P., Birkmayer, W., Neumayer, E., Ambrozi, L., Linauer, W.: The daily rhythm of HVA, VMA, VA and 5-HIAA in depression syndrom. J. Neural Transm.35, 23?45 (1974).","journal-title":"J. Neural Transm."},{"key":"CR42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/acps.1980.61.s280.251","volume":"Suppl. 280","author":"P. Riederer","year":"1980","unstructured":"Riederer, P., Birkmayer, W., Seemann, D., Wuketich, S.: 4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depression. Acta Psych. Scand., Suppl. 280, 251?257 (1980).","journal-title":"Acta Psych. Scand."},{"key":"CR43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00006842-197011000-00004","volume":"32","author":"R. T. Rubin","year":"1970","unstructured":"Rubin, R. T., Miller, R. G., Clark, B. R., Poland, R. E., Arthur, R. J.: The stress of air craft carrier landings: II. 3-methoxy-4-hydroxyphenylglycol excretion in naval aviators. Psychosom. Med.32, 589?597 (1970).","journal-title":"Psychosom. Med."},{"key":"CR44","first-page":"473","volume":"14","author":"E. Sacchetti","year":"1979","unstructured":"Sacchetti, E., Allaria, E., Negri, F., Biondi, P. A., Smeraldi, E., Cazzulo, C. L.: 3-methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations. Biol. Psychiat.14, 473?484 (1979).","journal-title":"Biol. Psychiat."},{"key":"CR45","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/0006-2952(68)90119-6","volume":"17","author":"S. M. Schanberg","year":"1968","unstructured":"Schanberg, S. M., Breese, G. R., Schildkraut, J. J., Gordon, E. K., Kopin, I. J.: 3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. Biochem. Pharmacol.17, 2006?2008 (1968).","journal-title":"Biochem. Pharmacol."},{"key":"CR46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-2952(68)90330-4","volume":"17","author":"S. M. Schanberg","year":"1968","unstructured":"Schanberg, S. M., Schildkraut, J. J., Breese, G. R., et al.: Metabolism of normetanephrine H3 in rat brain: identification of conjugated 3-methoxy-4-hydroxyphenylglycol as major metabolite. Biochem. Pharmacol.17, 247?254 (1968 b).","journal-title":"Biochem. Pharmacol."},{"key":"CR47","first-page":"98","volume-title":"Pharmakopsychiatr., Vol. 7","author":"J. J. Schildkraut","year":"1974","unstructured":"Schildkraut, J. J.: Biochemical criteria for classifying depressive disorders and predicting responses to pharmaco-therapy: preliminary findings from studies of norepinephrine metabolism. In: Pharmakopsychiatr., Vol. 7, pp. 98?107. Stuttgart: G. Thieme. 1974."},{"key":"CR48","first-page":"1223","volume-title":"Psychopharmacology: A Generation of Progress","author":"J. J. Schildkraut","year":"1978","unstructured":"Schildkraut, J. J.: Current status of the catecholamine hypothesis of affective disorders. In: Psychopharmacology: A Generation of Progress (Lipton, M. A., Di Mascio, A., Killam, K. F., eds.), pp. 1223?1234. New York: Raven Press. 1978."},{"key":"CR49","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archpsyc.1978.01770360040004","volume":"35","author":"J. J. Schildkraut","year":"1978","unstructured":"Schildkraut, J. J., Orsulak, P. J., Labrie, R. A., Schatzberg, A. F., Gudeman, A. E., Cole, J. O., Rohde, W. A.: Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Arch. Gen. Psych.35, 1436?1439 (1978 a).","journal-title":"Arch. Gen. Psych."},{"key":"CR50","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archpsyc.1978.01770360031003","volume":"35","author":"J. J. Schildkraut","year":"1978","unstructured":"Schildkraut, J. J., Orsulak, P. J., Schatzberg, A. F., Gudeman, A. E., Cole, J. O., Rohde, W. A., Labrie, R. A.: Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depression. Arch. Gen. Psych.35, 1427?1433 (1978 b).","journal-title":"Arch. Gen. Psych."},{"key":"CR51","first-page":"79","volume-title":"Frontiers in Biochemical and Pharmacological Research in Depression","author":"G. Sedvall","year":"1984","unstructured":"Sedvall, G., Iselius, L., Nyback, H., Oreland, L., Oxenstierna, G., Ross, S. B., Wiesel, F. A.: Genetic studies of CSF monoamine metabolites. In: Frontiers in Biochemical and Pharmacological Research in Depression (Usdin, E., \u00c5sberg, M., Bertilsson, L., Sj\u00f6qvist, F., eds.), pp. 79?97. New York: Raven Press. 1984."},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(69)90152-X","volume":"18","author":"H. Shimizu","year":"1969","unstructured":"Shimizu, H., Labrosse, E. H.: Metabolism of catecholamines-identification and quantification of 3-methoxy-4-hydroxyphenylglycol glucuronide in human urine. Biochem. Pharmacol.18, 1643?1654 (1969).","journal-title":"Biochem. Pharmacol."},{"key":"CR53","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/archpsyc.1978.01770360022002","volume":"35","author":"D. R. Sweeny","year":"1978","unstructured":"Sweeny, D. R., Maas, D. W., Heninger, G. R.: State anxiety, physical activity and urinary 3-methoxy-4-hydroxyphenylglycol excretion. Arch. Gen. Psychiat.35, 1418?1423 (1978).","journal-title":"Arch. Gen. Psychiat."},{"key":"CR54","first-page":"1213","volume-title":"Psychopharmacology: A Generation of Progress","author":"G. Winokur","year":"1978","unstructured":"Winokur, G.: Mania and depression: family studies and genetics in relation to treatment. In: Psychopharmacology: A Generation of Progress (Lipton, M. A., Di Mascio, A., Killam, K. F., eds.), pp. 1213?1221. New York: Raven Press. 1978."},{"key":"CR55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.1971.01750070067009","volume":"24","author":"R. J. Wyatt","year":"1971","unstructured":"Wyatt, R. J., Portnoy, B., Kupfer, D. J., Snyder, F., Engelman, K.: Resting plasma catecholamine concentration in patients with depression and anxiety. Arch. Gen. Psych.24, 65?70 (1971).","journal-title":"Arch. Gen. Psych."}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01252030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01252030\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01252030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T10:48:04Z","timestamp":1556794084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01252030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":55,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["BF01252030"],"URL":"https:\/\/doi.org\/10.1007\/bf01252030","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}